References
Dalen JE, Hirsh J, eds. Fourth ACCP Consensus Conference on Antithrombotic Therapy. Chest 1995;108:225S–522S.
Eritsland J, Arnesen H, Gronseth K, Fjeld NB, Abdelnoor M. Effect of dietary supplementation with n-3 fatty acids on coronary artery bypass artery graft patency. Am J Cardiol 1996;77:31–36.
Schulman S, Rhedin AS, Lindmarker P, et al. A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism. N Engl J Med 1995;332:1661–1665.
European Atrial Fibrillation Trial Study Group. Optimal oral anticoagulant therapy in patients with non-rheumatic atrial fibrillation and recent cerebral ischemia. N Engl J Med 1995;333:5–10.
Cappelleri JC, Fiore LD, Bruphy MT, Deykin D, Lau J. Efficacy and safety of combined anticoagulant and antiplatelet therapy versus anticoagulant monotherapy after mechanical heart valve replacement: A metaanalysis. Am Heart J 1995;130:547–552.
van Bergen PF, Deckers JW, Jonker JJ, von Domburg RT, Azar AJ, Hofman A. Efficiency of long-term anticoagulation treatment in subgroups of patients after myocardial infarction. Br Heart J 1995;74:117–121.
Antman EM, for the TIMI Investigators. Heparin vs. hirudin as adjunctive therapy for thrombolysis in MI: TIMI 9. Presented at the 11th International Workshop of Thrombolysis and Interventional Therapy in Acute Myocardial Infarction, American Heart Association Scientific Sessions; Anaheim, CA, November 1995.
van der Meer J, Brutel de la Riviere A, van Gilst WH, et al. Effects of low-dose aspirin (50 mg/day), low dose aspirin plus dipyridamole, and oral anticoagulant agents after internal mammary artery bypass grafting: Patency and clinical outcome at 1 year. J Am Coll Cardiol 1994;24:1181–1188.
The National Institute of Neurologic Disorders and Stroke r-tPA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995;333:1581–1587.
Kay R, Wong KS, Yu LY, et al. Low-molecular weight heparin for the treatment of acute ischemic stroke. N Engl J Med 1995;333:1588–1593.
Brack MJ, Ray S, Chauhan A, et al. The subcutaneous heparin and angioplasty restenosis prevention (SHARP) trial. Results of a multicenter randomized trial investigating the effects of high dose unfractionated heparin on angiographic restenosis and clinical outcome. J Am Coll Cardiol 1995;26:947–954.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Spencer, F., Becker, R.C. Current approach to antithrombotic therapy: An abbreviated reference for practicing clinicians. J Thromb Thrombol 3, 307–325 (1996). https://doi.org/10.1007/BF00133074
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00133074